An observational study in Myopia and High Myopia, sponsored by Suphi Taneri. Recruiting at 1 site in Germany. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Suphi Taneri · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 16 studies in Myopia with a site in Germany — 3 open to participants now, 4 under way, 1 of them phase 3. Myopia · Germany.
Among the 16 studies in Myopia with a site in Germany, this one is the only one that started in 2016, is one of 5 observational ones, and was the 9th registered.
1,166 studies on the registry are indexed under Myopia; 228 are open to participants now.
Browse Myopia studies →3 of the 16 studies in Myopia with a site in Germany are open now. Recruiting first, the newest first:
Biotech Healthcare Holding Gmbh · Sites in Germany, India
Ages 21+
University Hospital Augsburg · Sites in Germany
Ages 18+ · Healthy volunteers
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 124 Myopia studies recruiting now, 20 (16%) set no upper age limit and 103 (83%) stop at 75 or younger; 85 take children under 18; 53 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 1 · Phase 3 3
First in 2008; this study’s year is marked. 1 started in 2016.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 5,000 is above the median of 150 across 205 observational studies indexed under Myopia.
Median enrollment 172 across the 11 interventional studies, 237 across the 5 observational. Of the 11 that completed or were terminated, 2 (18%) have results posted.
This tab as a report to print or save as PDF → With an account.
11 of 16 have an industry lead sponsor. The 10 most frequent:
Suphi Taneri is the lead sponsor of 2 studies on the registry; 1 is open to participants now.
Suphi Taneri has 1 study filed under Myopia — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 16 studies in Myopia with a site in Germany, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Small Incision Lenticule Extraction (SMILE) was introduced in 2011 using the VISUMAX femtosecond laser (Carl Zeiss Meditec, Jena, Germany). It is designed for correction of myopia and myopic astigmatism.
It involves the creation of a corneal tissue disk called lenticule and its extraction through a minimally invasive incision, utilizing only a femtosecond laser. This enables rapid visual recovery with very little discomfort to the patient.
This observational case series monitors visual and refractive outcomes of myopic correction for more than -7.75 D.
It is to
Adult patients with myopia more than -7.75 D seeking refractive surgery
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
SMILE - Correction of eyes with myopia of more than -7.75 D
Other: Small Incision Lenticule Extraction (SMILE) with Visumax (Carl Zeiss Meditec, Jena)
Creation of a corneal tissue disk called lenticule and extraction through a minimally invasive incision, utilizing only a femtosecond laser
Also known as: RelaxSmile
Subjective Distance Refraction
Subjective Refraction
Time frame: 1 year
Distance Visual Acuity
Visual Acuity sine and cum correctione
Time frame: 1 year
Tectonic stability as assessed by Pentacam
Corneal tectonic stability post surgery as assesed by Scheimpflug-Tomography
Time frame: 1 year
Epithelial thickness map in Optical coherence tomography
Change of Thickness of epithelium pre and post surgery
Time frame: 1 year
Started Jan 2016 (actual). Primary completion is estimated for Nov 2029, 166 months after the start.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Suphi Taneri